首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Liver allografts are toleragenic in rats conditioned with posttransplant total lymphoid irradiation.
【24h】

Liver allografts are toleragenic in rats conditioned with posttransplant total lymphoid irradiation.

机译:在移植后总淋巴样照射条件下的大鼠中,肝脏同种异体移植具有耐受性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Posttransplant total lymphoid irradiation (TLI) treatment has been applied to tolerance induction protocols in heart and kidney transplantation models. METHODS: We examined the efficacy and mechanism of posttransplant TLI treatment in the induction and maintenance of tolerance in a rat orthotopic liver transplantation model. RESULTS: Posttransplant TLI prolonged ACI (RT1(a)) liver allograft survival in Lewis (RT1(b)) hosts, with 50% long-term engraftment without immunosuppression and without evidence of chronic rejection. Injection of donor-type liver mononuclear cells (LMCs) facilitated the prolongation of graft survival, with more than 70% of grafts in LMC recipients surviving more than 100 days without chronic rejection. Recipients with long-term liver allograft survival accepted ACI but not PVG skin grafts. In TLI-conditioned recipients with accepted grafts, apoptosis occurred predominantly in graft-infiltrating leukocytes. In contrast, there were few apoptotic leukocytes in rejecting grafts. Recipients with long-term graft acceptance (>100 days of survival) demonstrated evidence of immune deviation; mixed lymphocyte reaction to ACI stimulator cells was vigorous, but secretion of interferon-gamma and interleukin-2 was reduced. In tolerant recipients, the number of Foxp3(+) CD25(+) CD4(+) regulatory T cells was increased in the liver allograft as well as in the peripheral blood. CONCLUSION: We conclude that posttransplant TLI induces tolerance to liver allografts via a mechanism involving apoptotic cell-deletion and immunoregulation.
机译:背景:移植后全淋巴照射(TLI)处理已应用于心脏和肾脏移植模型中的耐受诱导方案。方法:我们研究了大鼠原位肝移植模型中TLI治疗在诱导和维持耐受性中的功效和机制。结果:移植后TLI延长了Lewis(RT1(b))宿主的ACI(RT1(a))肝脏同种异体移植存活,长期移植率为50%,无免疫抑制作用且无慢性排斥迹象。注射供体型肝单核细胞(LMC)有助于延长移植物存活,LMC接受者中超过70%的移植物存活100天以上而无慢性排斥。具有长期肝移植存活的接受者接受ACI,但不接受PVG皮肤移植。在接受移植的TLI条件接受者中,凋亡主要发生在移植物浸润的白细胞中。相反,排斥移植物的凋亡白细胞很少。长期接受移植物(> 100天生存期)的受试者表现出免疫偏差的证据;混合淋巴细胞对ACI刺激细胞的反应剧烈,但干扰素-γ和白介素2的分泌减少。在耐受的受体中,肝脏同种异体移植物和外周血中Foxp3(+)CD25(+)CD4(+)调节性T细胞的数量增加。结论:我们得出的结论是,移植后TLI通过涉及凋亡细胞缺失和免疫调节的机制诱导对肝同种异体移植的耐受。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号